The half-century-long quest to develop a male birth control pill has just gotten a boost from an unexpected corner: a Boston laboratory working to craft potent anti-cancer drugs. James Bradner, HMS assistant professor of medicine at Dana-Farber Cancer Institute, is the lead author. David Clapham, the Aldo R. Castaneda Professor of Cardiovascular Research at Boston Children’s Hospital, is also quoted.
